Please enable JavaScript to continue using this application.

Compare $BDTX vs $CNXU | Chartloom

Compare

$BDTX vs $CNXU

Black Diamond Therapeutics Inc · Conexeu Sciences Inc

BDTX

Black Diamond Therapeutics Inc

CNXU

Conexeu Sciences Inc

Compare $BDTX vs $CNXU

Comparing Black Diamond Therapeutics Inc and Conexeu Sciences Inc

BDTXBlack Diamond Therapeutics Inc

CNXUConexeu Sciences Inc

BDTXBlack Diamond Therapeutics Inc

Market cap

$105M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-26.5%

52W performance

-54.1%

FCF yield

-31.3%

CNXUConexeu Sciences Inc

Market cap

$104M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.2%

52W performance

-70.2%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDTX

CNXU

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

CNXU

Conexeu Sciences Inc

Market Cap

BDTX$105M

CNXU$104M

Enterprise Value

BDTX$86M

CNXU$102M

Price

BDTX$1.83

CNXU$3.89

P/E Ratio

BDTXN/A

CNXUN/A

P/S Ratio

BDTX0.00x

CNXU0.00x

EV/Sales

BDTX0.00x

CNXU0.00x

EV/EBITDA

BDTX6.96x

CNXU0.00x

P/B Ratio

BDTX1.13x

CNXU14.95x

P/FCF Ratio

BDTXN/A

CNXUN/A

EV/FCF

BDTX-2.61x

CNXU-8.61x

PEG Ratio

BDTXN/A

CNXUN/A

Forward P/E (NTM)

BDTXN/A

CNXUN/A

Forward P/S (NTM)

BDTXN/A

CNXUN/A

Revenue (TTM)

BDTX$0

CNXU$0

Revenue Growth (YoY)

BDTX-100.0%

CNXUN/A

Forward Rev Growth

BDTX533.3%

CNXU88.8%

Gross Margin (TTM)

BDTX0.0%

CNXU0.0%

Operating Margin (TTM)

BDTX0.0%

CNXU0.0%

EBITDA Margin (TTM)

BDTX0.0%

CNXU0.0%

Net Margin (TTM)

BDTX0.0%

CNXU0.0%

FCF Margin (TTM)

BDTXN/A

CNXUN/A

Net Income (TTM)

BDTX$-43M

CNXU$-16M

FCF (TTM)

BDTX$-33M

CNXU$-12M

EPS (TTM)

BDTX-$0.74

CNXU-$0.58

ROE (TTM)

BDTX-3880.0%

CNXU-23026.0%

ROA (TTM)

BDTX-3047.0%

CNXU-20389.0%

ROIC (TTM)

BDTX-3880.0%

CNXU-23026.0%

Cash

BDTX$19M

CNXU$2M

Debt

BDTX$0

CNXU$0

Net Cash/Debt

BDTX$19M

CNXU$2M

Current Ratio (TTM)

BDTX7.28x

CNXU5.31x

Quick Ratio (TTM)

BDTX6.98x

CNXU1.74x

Debt/Equity (TTM)

BDTX0.00x

CNXU0.00x

Debt/Assets (TTM)

BDTX0.0%

CNXU0.0%

Interest Coverage (TTM)

BDTXN/A

CNXUN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

CNXU0.00x

Beta

BDTX3.41

CNXU-2.20

52W Performance

BDTX-54.1%

CNXU-70.2%

YTD Performance

BDTX-26.5%

CNXU-70.2%

% from 52W High

BDTX-63.0%

CNXU-79.3%

% from 52W Low

BDTX14.4%

CNXU27.5%

Asset Turnover (TTM)

BDTX0.00x

CNXU0.00x

FCF Yield (TTM)

BDTX-31.3%

CNXU-11.4%

Earnings Yield (TTM)

BDTX-40.6%

CNXU-15.1%

Dividend Yield (TTM)

BDTXN/A

CNXUN/A

Rule of 40

BDTX-100.0

CNXU0.0

EV/GP/RG

BDTXN/A

CNXUN/A

Ticker research

View BDTX research View CNXU research

Metric	BDTX Black Diamond Therapeutics Inc	CNXU Conexeu Sciences Inc
Market & Valuation
Market Cap	$105M	$104M
Enterprise Value	$86M	$102M
Price	$1.83	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	14.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-8.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	88.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-16M
FCF (TTM)	$-33M	$-12M
EPS (TTM)	-$0.74	-$0.58
ROE (TTM)	-3880.0%	-23026.0%
ROA (TTM)	-3047.0%	-20389.0%
ROIC (TTM)	-3880.0%	-23026.0%
Financial Health
Cash	$19M	$2M
Debt	$0	$0
Net Cash/Debt	$19M	$2M
Current Ratio (TTM)	7.28x	5.31x
Quick Ratio (TTM)	6.98x	1.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	-2.20
52W Performance	-54.1%	-70.2%
YTD Performance	-26.5%	-70.2%
% from 52W High	-63.0%	-79.3%
% from 52W Low	14.4%	27.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.3%	-11.4%
Earnings Yield (TTM)	-40.6%	-15.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View CNXU research

Valuation

P/S Ratio

BDTX

0.00x

CNXU

0.00x

EV/FCF

CNXU

-8.61x

BDTX

-2.61x

Growth & revenue

Revenue Growth TTM

BDTX

-100.0%

Forward Revenue Growth

BDTX

533.3%

CNXU

88.8%

Profitability & performance

Gross Margin

BDTX

0.0%

CNXU

0.0%

ROE

BDTX

-3880.0%

CNXU

-23026.0%

FCF Yield %

CNXU

-11.4%

BDTX

-31.3%

52-Week Performance

BDTX

-54.1%

CNXU

-70.2%

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

CNXU

Conexeu Sciences Inc

Market Cap

BDTX$105M

CNXU$104M

Enterprise Value

BDTX$86M

CNXU$102M

Price

BDTX$1.83

CNXU$3.89

P/E Ratio

BDTXN/A

CNXUN/A

P/S Ratio

BDTX0.00x

CNXU0.00x

EV/Sales

BDTX0.00x

CNXU0.00x

EV/EBITDA

BDTX6.96x

CNXU0.00x

P/B Ratio

BDTX1.13x

CNXU14.95x

P/FCF Ratio

BDTXN/A

CNXUN/A

EV/FCF

BDTX-2.61x

CNXU-8.61x

PEG Ratio

BDTXN/A

CNXUN/A

Forward P/E (NTM)

BDTXN/A

CNXUN/A

Forward P/S (NTM)

BDTXN/A

CNXUN/A

Revenue (TTM)

BDTX$0

CNXU$0

Revenue Growth (YoY)

BDTX-100.0%

CNXUN/A

Forward Rev Growth

BDTX533.3%

CNXU88.8%

Gross Margin (TTM)

BDTX0.0%

CNXU0.0%

Operating Margin (TTM)

BDTX0.0%

CNXU0.0%

EBITDA Margin (TTM)

BDTX0.0%

CNXU0.0%

Net Margin (TTM)

BDTX0.0%

CNXU0.0%

FCF Margin (TTM)

BDTXN/A

CNXUN/A

Net Income (TTM)

BDTX$-43M

CNXU$-16M

FCF (TTM)

BDTX$-33M

CNXU$-12M

EPS (TTM)

BDTX-$0.74

CNXU-$0.58

ROE (TTM)

BDTX-3880.0%

CNXU-23026.0%

ROA (TTM)

BDTX-3047.0%

CNXU-20389.0%

ROIC (TTM)

BDTX-3880.0%

CNXU-23026.0%

Cash

BDTX$19M

CNXU$2M

Debt

BDTX$0

CNXU$0

Net Cash/Debt

BDTX$19M

CNXU$2M

Current Ratio (TTM)

BDTX7.28x

CNXU5.31x

Quick Ratio (TTM)

BDTX6.98x

CNXU1.74x

Debt/Equity (TTM)

BDTX0.00x

CNXU0.00x

Debt/Assets (TTM)

BDTX0.0%

CNXU0.0%

Interest Coverage (TTM)

BDTXN/A

CNXUN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

CNXU0.00x

Beta

BDTX3.41

CNXU-2.20

52W Performance

BDTX-54.1%

CNXU-70.2%

YTD Performance

BDTX-26.5%

CNXU-70.2%

% from 52W High

BDTX-63.0%

CNXU-79.3%

% from 52W Low

BDTX14.4%

CNXU27.5%

Asset Turnover (TTM)

BDTX0.00x

CNXU0.00x

FCF Yield (TTM)

BDTX-31.3%

CNXU-11.4%

Earnings Yield (TTM)

BDTX-40.6%

CNXU-15.1%

Dividend Yield (TTM)

BDTXN/A

CNXUN/A

Rule of 40

BDTX-100.0

CNXU0.0

EV/GP/RG

BDTXN/A

CNXUN/A

Ticker research

View BDTX research View CNXU research

Metric	BDTX Black Diamond Therapeutics Inc	CNXU Conexeu Sciences Inc
Market & Valuation
Market Cap	$105M	$104M
Enterprise Value	$86M	$102M
Price	$1.83	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	14.95x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-8.61x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	88.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-16M
FCF (TTM)	$-33M	$-12M
EPS (TTM)	-$0.74	-$0.58
ROE (TTM)	-3880.0%	-23026.0%
ROA (TTM)	-3047.0%	-20389.0%
ROIC (TTM)	-3880.0%	-23026.0%
Financial Health
Cash	$19M	$2M
Debt	$0	$0
Net Cash/Debt	$19M	$2M
Current Ratio (TTM)	7.28x	5.31x
Quick Ratio (TTM)	6.98x	1.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	-2.20
52W Performance	-54.1%	-70.2%
YTD Performance	-26.5%	-70.2%
% from 52W High	-63.0%	-79.3%
% from 52W Low	14.4%	27.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-31.3%	-11.4%
Earnings Yield (TTM)	-40.6%	-15.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View CNXU research